Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it will webcast its corporate presentation at the 14th Annual BIO CEO + Investor Conference on Monday, February 13, 2012, ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) announced that the hearing on the Company’s claims in the demand for arbitration under the applicable provisions ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced the promotion of Birgit Roerig, Ph.D. to Vice President, Pharmacology and Toxicology at Sucampo ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (Sucampo) today announced that it will present, with materials, at the 2011 Credit Suisse Annual Health Care Conference on Thursday, November 10, 2011, ... read more

Sucampo Pharmaceuticals, Inc. (“Sucampo”), (NASDAQ: SCMP) (SPI), an international pharmaceutical company, today reported its consolidated financial results for the quarter and year-to-date ended September 30, ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced the appointment of Cary J. Claiborne as SPI’s Chief Financial Officer (CFO), effective ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it will host a webcast and teleconference with senior management to discuss its financial results as well as provide a ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (Sucampo) today announced that its presentation at the 18th Annual Newsmakers in the Biotech Industry Conference, sponsored by BioCentury and ThomsonReuters, ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI), an international pharmaceutical company, today announced that Greg Deener has joined Sucampo Pharma Americas, Inc. (SPA), ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), an international pharmaceutical company, today announced that its Board of Directors has approved the repurchase of up to an aggregate of $2,000,000 of ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI), an international pharmaceutical company, today announced leadership changes within its research and development (R&D) group. Effective ... read more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), an international pharmaceutical company, today announced that Daniel P. Getman, Ph.D., President, Kansas ... read more